When the FDA declared a semaglutide shortage, adding Wegovy to the shortage list in March 2022, followed by Ozempic in August 2022, companies like Medvi and Hims & Hers began selling compounded versions of semaglutide at a lower cost and without going through the standard approval process
Retatrutide, also known by the research identifier LY3437943 , is a synthetic investigational peptide studied for its interaction with three receptor systems: GLP-1 , GIP , and glucagon receptors
Temporary change (one week only) Use a temporary change for vacations, travel days, or a single appointment that clashes with your usual injection time
In practice, most clinicians would likely taper tirzepatide down before initiating retatrutide to manage overlapping GI side effects and assess the new compound's individual response
Product description Natural & Gentle Formula Featuring a liquid drop design GLP-1 Drops is suitable for all types of adults and can be taken as little as 1-2 dropperful 2-3 times a day Providing a sense of comfort and reassurance with every use
Most people noticing this effect are already taking semaglutide for diabetes or weight management
